CN111513157A - 一种含枸杞决明子的养生茶及其制作方法 - Google Patents
一种含枸杞决明子的养生茶及其制作方法 Download PDFInfo
- Publication number
- CN111513157A CN111513157A CN202010402181.6A CN202010402181A CN111513157A CN 111513157 A CN111513157 A CN 111513157A CN 202010402181 A CN202010402181 A CN 202010402181A CN 111513157 A CN111513157 A CN 111513157A
- Authority
- CN
- China
- Prior art keywords
- parts
- tea
- medlar
- cassia seed
- soaking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000037364 Cinnamomum aromaticum Species 0.000 title claims abstract description 24
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 title claims abstract description 24
- 230000036541 health Effects 0.000 title claims abstract description 20
- 235000017784 Mespilus germanica Nutrition 0.000 title claims abstract description 15
- 244000182216 Mimusops elengi Species 0.000 title claims abstract description 15
- 235000000560 Mimusops elengi Nutrition 0.000 title claims abstract description 15
- 235000007837 Vangueria infausta Nutrition 0.000 title claims abstract description 15
- 244000269722 Thea sinensis Species 0.000 title abstract description 43
- 238000002360 preparation method Methods 0.000 title abstract description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 18
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 16
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 16
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 16
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 13
- 229930006000 Sucrose Natural products 0.000 claims abstract description 13
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 13
- 235000012907 honey Nutrition 0.000 claims abstract description 12
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims abstract description 4
- 244000241838 Lycium barbarum Species 0.000 claims abstract 6
- 238000002791 soaking Methods 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 241000723353 Chrysanthemum Species 0.000 claims description 12
- 238000001816 cooling Methods 0.000 claims description 10
- 238000009835 boiling Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 3
- 241001122767 Theaceae Species 0.000 claims 10
- 230000000694 effects Effects 0.000 abstract description 17
- 241000894006 Bacteria Species 0.000 abstract description 4
- 230000004438 eyesight Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract description 2
- 206010013774 Dry eye Diseases 0.000 abstract description 2
- 206010014970 Ephelides Diseases 0.000 abstract description 2
- 208000003351 Melanosis Diseases 0.000 abstract description 2
- 241000700605 Viruses Species 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 230000002087 whitening effect Effects 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 38
- 244000241872 Lycium chinense Species 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 6
- 241000169546 Lycium ruthenicum Species 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 229940126673 western medicines Drugs 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 235000015091 medicinal tea Nutrition 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- VGGGPCQERPFHOB-MCIONIFRSA-N Bestatin Chemical compound CC(C)C[C@H](C(O)=O)NC(=O)[C@@H](O)[C@H](N)CC1=CC=CC=C1 VGGGPCQERPFHOB-MCIONIFRSA-N 0.000 description 1
- VGGGPCQERPFHOB-UHFFFAOYSA-N Bestatin Natural products CC(C)CC(C(O)=O)NC(=O)C(O)C(N)CC1=CC=CC=C1 VGGGPCQERPFHOB-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229940099690 malic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 231100000483 muscle toxicity Toxicity 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 229950009811 ubenimex Drugs 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels, liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及保健品领域，特别指一种含枸杞决明子的养生茶及其制作方法，包括以下按重量份计的原料组成：决明子1～3份，菊花1～3份，黑枸杞2～4份，红枸杞2～4份，柠檬1～2份，其余为茶叶，还包括辅料枣圈1～2份、蜂蜜或白糖2～4份。本发明有缓解疲劳以及眼睛干涩，清热去火，提神醒脑，明目滋阴，补肾壮阳，强身健体，美白祛斑，抗菌抗病毒等多种特效，本发明不仅具有降血压血脂，经常饮用还有抗衰老，治疗高血压的特效，而且本发明也可以外用，当皮肤出现烫伤能有效缓解疼痛及有效治疗效果。
Description
技术领域
本发明涉及保健品领域，特别指一种含枸杞决明子的养生茶及其制作方法。
背景技术
药茶又称茶剂，即将中草药(单味或复方)配有茶叶或不配有茶叶的药物经加工而成的制剂。在应用时多采取沸水浸泡取汁服或加水煎汁服，可随时代茶饮而起到治疗疾病或保健养生的作用。把中药传统的药剂疗法改革成冲泡饮食疗法，可达到既方便又能保证药效的目的。
药茶具有以下特点：1、饮服方便。沸水冲泡，其操作灵活，程序简单，适应各种国际化工作和生活节奏加快的发展趋势；2、浸泡药物时，以沸水为溶媒，可将共中的酶迅速杀灭，避免有效成分的分解和破坏；3、药物为粗粉或细丝、小段，其表面面积大，与溶媒的接触面大，易使有效成分溶出；4、可以多次重复浸泡，使药物的有效成份充分溶解溢出宜。
目前，由于现代生活的原因，高血糖、高血脂、高血压逐渐成为威胁人类健康的三大杀手，并呈现年轻化的趋势，已经严重影响了人们的生活质量。
血脂，指血液中所含脂类的总称，包括：甘油三酯(TG)、胆固醇(TC)、B脂蛋白、磷脂和游离脂酸等，它们在血液中含量高低受到年龄、性别、饮食成分、脂质代谢功能、遗传因素、精神活动和疾病等诸多因素的影响而处于动态平衡。随着生活水平的提高，饮食结构的改变，膏梁厚味，嗜饮醇酒，伴随而来的是高血脂、高血压、糖尿病等“富贵病”的增加。其中高血脂是导致脑血栓、冠心病等多种心脑血管疾病的罪魁祸首，严重影响着人们的身体健康。
西药调节血脂虽有肯定的疗效，但有不同程度的副作用。目前公认调脂最有效并广泛应用的西药是他汀类，但费用高，且有肝脏和肌肉毒性等副作用，严重者可导致横纹肌溶解症(Rhabdomyolysis)。降血脂药拜斯亭因有副作用发生已被停用。中药调脂以其疗效好、副作用小的优势而成为研究的热点，因此，开发天然的降血脂符合中药治疗要求的，方便实用的养生茶具有广阔的市场前景。
发明内容
为了解决上述技术问题，本发明提供一种安全、无副作用，能够降血压血脂的养生茶及其制作方法。
一种含枸杞决明子的养生茶，包括以下按重量份计的原料组成：决明子1～3份，菊花1～3份，黑枸杞2～4份，红枸杞2～4份，柠檬1～2份，其余为茶叶。
进一步地，还包括辅料枣圈1～2份、蜂蜜或白糖2～4份。
进一步地，包括以下按重量份计的原料组成：决明子1份，菊花1份，黑枸杞2份，红枸杞2份，柠檬1份，枣圈1份，蜂蜜或白糖2份。
一种如权利要求1所述的含枸杞决明子的养生茶的制作方法，包括以下步骤：
首先将茶叶采用沸水浸泡10～15秒，过滤掉茶叶，将决明子、菊花放入获得的茶叶水内浸泡5～15分钟时间；待浸泡有决明子、菊花的茶水在浸泡过程中，温度冷却至60～65℃，加入柠檬片浸泡，继续冷却至55～60℃加入黑枸杞和红枸杞浸泡，其中当温度降至在55～65℃范围内，可加入枣圈浸泡；继续冷却待温度降至不高于30℃，加入蜂蜜或者白糖，搅拌均匀或搅拌至白糖融化完全，最后使用过滤装置，过滤获得可饮用的茶水。
决明子：清肝明目，利水通便，有缓泻作用，降血压降血脂。
菊花：具有疏散风热、平抑肝阳、清肝明目、清热解毒的功效。
柠檬：具有生津解暑开胃、预防心血管疾病、抗菌消炎功效、延缓衰老抑制色素沉着等功效，柠檬富含维生素C、糖类、钙、磷、铁、维生素B1、维生素B2、烟酸、奎宁酸、柠檬酸、苹果酸、橙皮苷、柚皮苷、香豆精、高量钾元素和低量钠元素等，对人体十分有益。维生素C能维持人体各种组织和细胞间质的生成，并保持它们正常的生理机能。
茶叶：能减低心脑血管发病和死亡风险、有降低胆固醇和血压的作用、有抗压力和抗焦虑作用、提高免疫力等功效，其中茶多酚是茶叶中含量最多的一类可溶性成分，也是茶叶发挥其健康保健功效最主要的物质，最典型的代表是儿茶素(酚)，具有抗氧化(消除氧自由基)、抗炎、降低心血管病发病几率、预防癌症、降血脂、减少体脂形成、抗菌、改变肠道菌群生态等多项功效。研究表明，喝下一杯茶半小时后，血中的抗氧化容量(对抗氧自由基的能力)增加41％～48％，并能在高水平状态持续一个半小时。茶色素主要包括叶绿素、β-胡萝卜素等，具有抗肿癌、延缓衰老以及美容等作用。
蜂蜜：具有护肤美容、抗菌消炎、促进组织再生、促进消化、改善睡眠、保肝作用、抗疲劳、润肺祛痰止咳、祛湿利尿、凉血止血、宁心安神、清热解毒等功效。
另外，当有小面积烧伤或许烫坏，可用优质蜂蜜涂在创伤面上，能起到减轻苦楚，防止感染和推进创伤愈合的效果，蜂蜜呈微酸性，十分粘稠且吸水性极强，敷于烧烫坏的肌肤创面上会构成一层保护性薄膜，以促进坏死肌肤安排自行税落，并长出新鲜健康的肌肤。
枣：有养胃、健脾、益血、滋补、强身之效，枣仁和根均可入药。
本发明具有如下优点：本发明有缓解疲劳以及眼睛干涩，清热去火，提神醒脑，明目滋阴，补肾壮阳，强身健体，美白祛斑，抗菌抗病毒等多种特效，本发明不仅具有降血压血脂，经常饮用还有抗衰老，治疗高血压的特效，而且本发明也可以外用，当皮肤出现烫伤能有效缓解疼痛及有效治疗效果。
具体实施方式
本发明的具体实施方式：
本发明一种含枸杞决明子的养生茶的制作方法，包括以下步骤：
步骤一、按照重量份计的原料组成称取各成分决明子1份，菊花1份，黑枸杞2份，红枸杞2份，柠檬1份，枣圈1份，蜂蜜或白糖2份，其余为茶叶，茶叶选用制备好的绿茶或者红茶，其中黑枸杞或者红枸杞每份5颗量，柠檬片每份2片量，蜂蜜或白糖每份为5g量。
步骤二、首先将茶叶采用沸水浸泡10～15秒，过滤掉茶叶，茶叶浸泡时间端，获得的茶叶水温度扔在90℃以上，将决明子、菊花放入获得的茶叶水内浸泡5～15分钟时间；
步骤三、待浸泡有决明子、菊花和茶叶的茶水在浸泡过程中，温度冷却至60～65℃，加入柠檬片浸泡，继续冷却至55～60℃加入黑枸杞和红枸杞浸泡，其中当温度降至在55～65℃范围内，可加入枣圈浸泡；
步骤四、继续冷却待温度降至不高于30℃，加入蜂蜜或者白糖，搅拌均匀或搅拌至白糖融化完全；
步骤五、最后使用过滤装置，过滤获得可饮用的茶水。
本发明黑枸杞或红枸杞、柠檬片或者枣圈都是60度左右的水泡的，不可同时使用沸水浸泡，同时用沸水泡的话，会破坏其营养物质，口感差，特别是柠檬片会导致喝的时候又酸又涩，蜂蜜在三十度以下有利于有效保留其营养成份，茶叶可根据自己喜欢的口味来选取绿茶或者红茶。
本发明在泡制过程中对各项成份配发比例，水温，泡的时间要特别注意，泡制时间过长易导致味道苦涩，过短导致营养成份无法有效发挥出来，温度过高或过低可能导致营养成份被破坏，可以替代咖啡等提神产品。
本发明的在使用时应注意：孕妇及7岁以下儿童禁用。
以上所述仅为本发明的优选实施方式而已，并不用于限制本发明，对于本领域的技术人员来说，本发明可以有各种更改和变化。凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种含枸杞决明子的养生茶，其特征在于，包括以下按重量份计的原料组成：决明子1～3份，菊花1～3份，黑枸杞2～4份，红枸杞2～4份，柠檬1～2份，其余为茶叶。
2.根据权利要求1所述的一种含枸杞决明子的养生茶，其特征在于：还包括辅料枣圈1～2份、蜂蜜或白糖2～4份。
3.根据权利要求1所述的一种含枸杞决明子的养生茶，其特征在于，包括以下按重量份计的原料组成：决明子1份，菊花1份，黑枸杞2份，红枸杞2份，柠檬1份，枣圈1份，蜂蜜或白糖2份。
4.一种如权利要求1所述的含枸杞决明子的养生茶的制作方法，其特征在于，包括以下步骤：
首先将茶叶采用沸水浸泡10～15秒，过滤掉茶叶，将决明子、菊花放入获得的茶叶水内浸泡5～15分钟时间；待浸泡有决明子、菊花的茶水在浸泡过程中，温度冷却至60～65℃，加入柠檬片浸泡，继续冷却至55～60℃加入黑枸杞和红枸杞浸泡，其中当温度降至在55～65℃范围内，可加入枣圈浸泡；继续冷却待温度降至不高于30℃，加入蜂蜜或者白糖，搅拌均匀或搅拌至白糖融化完全，最后使用过滤装置，过滤获得可饮用的茶水。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010402181.6A CN111513157A (zh) | 2020-05-13 | 2020-05-13 | 一种含枸杞决明子的养生茶及其制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010402181.6A CN111513157A (zh) | 2020-05-13 | 2020-05-13 | 一种含枸杞决明子的养生茶及其制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111513157A true CN111513157A (zh) | 2020-08-11 |
Family
ID=71904985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010402181.6A Pending CN111513157A (zh) | 2020-05-13 | 2020-05-13 | 一种含枸杞决明子的养生茶及其制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111513157A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115152867A (zh) * | 2021-04-06 | 2022-10-11 | 郝常贵 | 一种补充能量及改善微循环、降血脂的组方及制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564184A (zh) * | 2008-04-21 | 2009-10-28 | 曲奕 | 苦菜菊花降血脂减肥饮料 |
| CN109315514A (zh) * | 2018-09-25 | 2019-02-12 | 俞海英 | 一种提神茶饮及其制备方法 |
-
2020
- 2020-05-13 CN CN202010402181.6A patent/CN111513157A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101564184A (zh) * | 2008-04-21 | 2009-10-28 | 曲奕 | 苦菜菊花降血脂减肥饮料 |
| CN109315514A (zh) * | 2018-09-25 | 2019-02-12 | 俞海英 | 一种提神茶饮及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115152867A (zh) * | 2021-04-06 | 2022-10-11 | 郝常贵 | 一种补充能量及改善微循环、降血脂的组方及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101703134B (zh) | 一种保健茶 | |
| CN111919934A (zh) | 一种用于降三高保护心血管的红花苏心茶及其制备方法 | |
| CN110354204A (zh) | 一种具有明目功效的组合物及其制备、应用方法 | |
| JP2018510641A (ja) | 発毛促進、脱毛緩和及び改善、血糖調節、胃腸障害の症状緩和及び改善用健康補助食品 | |
| CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
| CN102100275B (zh) | 一种决明子茶 | |
| CN106490612A (zh) | 一种女性补益膏及制备方法 | |
| CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
| CN105495597A (zh) | 一种糖尿病人用抗衰老、美容养颜的阿胶糕及其制备方法 | |
| CN112970992A (zh) | 一种适合糖尿病人的固体饮料及制作方法 | |
| CN107384680B (zh) | 一种百香果龙眼果酒及其酿造方法 | |
| CN111513157A (zh) | 一种含枸杞决明子的养生茶及其制作方法 | |
| CN101755878A (zh) | 一种含有苦瓜山楂决明子的减肥蛋糕的制备方法 | |
| CN101955874B (zh) | 一种苦杏酒的酿造方法 | |
| CN104694315B (zh) | 一种防衰老葡萄酒及制备方法 | |
| CN105077501A (zh) | 一种青年女性用减肥饮料 | |
| CN108552368A (zh) | 一种润肤养颜糖茶 | |
| KR101227922B1 (ko) | 파파야 퓌레 조제품 및 그 제조방법 | |
| CN105995711A (zh) | 一种滇橄榄复方制剂及其制备方法 | |
| KR20110029280A (ko) | 한방비누 조성물 | |
| CN107384731B (zh) | 一种百香果龙眼果醋及其酿造方法 | |
| CN110122750A (zh) | 一种健康营养八宝粥 | |
| RU2792449C2 (ru) | Состав фиточая, содержащего биологически активные добавки | |
| JP6681496B1 (ja) | 健康増進食品の製造方法並びにその食品 | |
| KR20170121033A (ko) | 연령대별 여성에게 필요한 생약 성분을 함유한 입술용 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200811 |
|
| RJ01 | Rejection of invention patent application after publication |